Skip to main navigation Skip to search Skip to main content

Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study

  • ROMIAE study group
  • Ltd.
  • Sejong General Hospital
  • Samsung Medical Center, Sungkyunkwan university
  • Soonchunhyang University
  • Gyeongsang National University
  • Korea University
  • Kyungpook National University
  • Kyung Hee University
  • University of Ulsan
  • Ajou University
  • Ewha Womans University
  • Chonnam National University
  • Jeju National University
  • Chung-Ang University
  • Hallym University
  • Hanyang University
  • Incheon Sejong Hospital
  • Stanford University
  • CHA University
  • Ltd

Research output: Contribution to journalJournal articlepeer-review

Abstract

Background and Aims: Emerging evidence supports artificial intelligence-enhanced electrocardiogram (AI-ECG) for detecting acute myocardial infarction (AMI), but real-world validation is needed. The aim of this study was to evaluate the performance of AI-ECG in detecting AMI in the emergency department (ED). Methods: The Rule-Out acute Myocardial Infarction using Artificial intelligence Electrocardiogram analysis (ROMIAE) study is a prospective cohort study conducted in the Republic of Korea from March 2022 to October 2023, involving 18 university-level teaching hospitals. Adult patients presenting to the ED within 24 h of symptom onset concerning for AMI were assessed. Exposure included AI-ECG score, HEART score, GRACE 2.0 score, high-sensitivity troponin level, and Physician AMI score. The primary outcome was diagnosis of AMI during index admission, and the secondary outcome was 30 day major adverse cardiovascular event (MACE). Results: The study population comprised 8493 adults, of whom 1586 (18.6%) were diagnosed with AMI. The area under the receiver operating characteristic curve for AI-ECG was 0.878 (95% CI, 0.868-0.888), comparable with the HEART score (0.877; 95% CI, 0.869-0.886) and superior to the GRACE 2.0 score, high-sensitivity troponin level, and Physician AMI score. For predicting 30 day MACE, AI-ECG (area under the receiver operating characteristic, 0.866; 95% CI, 0.856-0.877) performed comparably with the HEART score (0.858; 95% CI, 0.848-0.868). The integration of the AI-ECG improved risk stratification and AMI discrimination, with a net reclassification improvement of 19.6% (95% CI, 17.38-21.89) and a C-index of 0.926 (95% CI, 0.919-0.933), compared with the HEART score alone. Conclusions: In this multicentre prospective study, the AI-ECG demonstrated diagnostic accuracy and predictive power for AMI and 30 day MACE, which was similar to or better than that of traditional risk stratification methods and ED physicians.

Original languageEnglish
Pages (from-to)1917-1929
Number of pages13
JournalEuropean Heart Journal
Volume46
Issue number20
DOIs
StatePublished - 2025.05.21

Keywords

  • AI/ML-enabled SaMD
  • Acute coronary syndrome
  • Acute myocardial infarction
  • Artificial intelligence
  • Electrocardiogram
  • Emergency department

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Fingerprint

Dive into the research topics of 'Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study'. Together they form a unique fingerprint.

Cite this